Clinical Trial Update: Donor Dopamine and Initial Graft Function [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether donor dopamine improves initial graft function after kidney transplantation in ESRD; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Dopamine (dopamine)

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Kidney Transplantation, ESRD | Phase 4 | Status: COMPLETED